IDiyas

For the Inventor, By the Inventor

Watchung, NJ, United States of America

Byron H Arison

USPTO Granted Patents = 45

Average Co-Inventor Count = 3.7

ph-index = 12

Forward Citations = 307(Granted Patents)


Location History:

  • Edison, NJ (US) (1992)
  • Watchung, NJ (US) (1981 - 2002)

Company Filing History:

goldMedal45 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1981-2002

Loading Chart...
45 patents (USPTO):Explore Patents
1. 6426353 - &agr; v integrin receptor antagonists (2002-07-30),
2. 5952347 - Quinoline leukotriene antagonists (1999-09-14),
3. 5612217 - Streptomyces sp. MA 7074 (ATCC 55605) used for microbial synthesis of (1997-03-18),
4. 5478929 - Bioconversion products of 27-hydroxy avermectin (1995-12-26),
5. 5468771 - Cholesterol lowering compound (1995-11-21),
6. 5362752 - Chemical compounds (1994-11-08),
7. 5359096 - Cholesterol lowering compounds (1994-10-25),
8. 5352783 - Microbial transformation product having immunosuppressive activity (1994-10-04),
9. 5324644 - Process for producing immunosuppressant agent (1994-06-28),
10. 5322855 - Cholesterol lowering compounds (1994-06-21),
11. 5317031 - Cholesterol lowering compounds (1994-05-31),
12. 5302604 - Cholesterol lowering compounds produced by directed biosynthesis (1994-04-12),
13. 5290772 - Immunosuppressant agent (1994-03-01),
14. 5273979 - C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent (1993-12-28),
15. 5272068 - Process for producing immunosuppressant agent L-683942 by fermentation (1993-12-21),

Title: Byron H Arison: A Creative Force in Innovation

Introduction:

Byron H Arison, hailing from Watchung, NJ, stands as a beacon of creativity and innovation, with a legacy that continues to inspire aspiring inventors and entrepreneurs around the world. With his remarkable contributions to the field of pharmaceuticals, Arison has left an indelible mark on the world of science and technology.

Latest Patents:

Arison's latest patents showcase his brilliance in developing groundbreaking pharmaceutical compounds. One of his notable inventions includes &agr; v integrin receptor antagonists, which have a wide range of applications such as inhibiting bone resorption, treating cancer and metastatic tumor growth. Another remarkable patent is the Quinoline leukotriene antagonists, which have proven effective in combating asthma, inflammation, and various other conditions.

Career Highlights:

Arison's illustrious career is deeply intertwined with Merck & Company, Inc., a renowned pharmaceutical company. With an impressive total of 45 patents to his name, Arison has been at the forefront of innovation in the pharmaceutical industry. His dedication to research and development has led to the creation of life-saving medications and treatments that have impacted countless lives.

Collaborations:

Throughout his career, Arison has collaborated with esteemed colleagues such as Shieh-Shung T Chen and Linda S Wicker. Together, they have worked tirelessly to push the boundaries of scientific discovery and bring revolutionary concepts to life. The synergy of their collective expertise has resulted in groundbreaking advancements in the field of pharmaceuticals.

Conclusion:

In conclusion, Byron H Arison's exceptional talent and unwavering commitment to innovation have established him as a true pioneer in the world of inventors. His profound impact on the field of pharmaceuticals serves as a testament to the transformative power of creativity and perseverance. As we look towards the future, Arison's legacy will undoubtedly continue to inspire generations of inventors to push the boundaries of what is possible in the realm of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…